Company intelligence / Profile preview

Genoheal

Seoul, Seoul, South Koreagenoheal.com ↗

Ownership: Private
Development stage: Other

Overview

Genoheal is a South Korean biotechnology and personalized healthcare company founded in 2015. The company leverages direct-to-consumer (DTC) genetic testing and genomic analysis to develop personalized skincare, inner beauty products, and therapeutic solutions. Genoheal's therapeutic pipeline focuses on women's health and reproductive medicine, specifically targeting female infertility (poor ovarian response) and male infertility. Its lead clinical program is a peony composite extract (CHOA_PLCR) in Phase 2 development for improving ovarian function in poor ovarian responders.

Therapeutic areas: Men's HealthWomen's HealthDermatology
Modalities: Botanical extractHerbal medicineSmall molecule
Industry: Biotech

Partnerships

Cho-A PharmJungwoo PharmaceuticalKorea Institute for Public Sperm BankPohang Women's Hospital

Beyond the preview

Go deeper on Genoheal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genoheal.